Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Nov 19:17:330.
doi: 10.1186/s13075-015-0838-4.

Tumor necrosis factor-α blockade in recurrent and disabling chronic sciatica associated with post-operative peridural lumbar fibrosis: results of a double-blind, placebo randomized controlled study

Affiliations
Randomized Controlled Trial

Tumor necrosis factor-α blockade in recurrent and disabling chronic sciatica associated with post-operative peridural lumbar fibrosis: results of a double-blind, placebo randomized controlled study

Christelle Nguyen et al. Arthritis Res Ther. .

Abstract

Introduction: The aim of this study was to assess the efficacy and safety of tumor necrosis factor (TNF)-α inhibition with infliximab (IFX) in treating recurrent and disabling chronic sciatica pain associated with post-operative peridural lumbar fibrosis.

Method: A double-blind, placebo-controlled study randomized 35 patients presenting with sciatica pain associated with post-operative peridural lumbar fibrosis to two groups: IFX (n = 18), a single intravenous injection of 3 mg/kg IFX; and placebo (n = 17), a single saline serum injection. The primary outcome was a 50 % reduction in sciatica pain on a visual analog scale (VAS) at day 10. Secondary outcomes were radicular and lumbar VAS pain at day 0 and radicular and lumbar VAS pain, Québec disability score, drug-sparing effect and tolerance at days 10, 30, 90, and 180.

Results: At day 10, the placebo and IFX groups did not differ in the primary outcome (50 % reduction in sciatica pain observed in three (17.6 %) versus five (27.8 %) patients; p = 0.69). The number of patients reaching the patient acceptable symptom state for radicular pain was significantly higher in the placebo than IFX group after injection (12 (70.6 %) versus five (27.8 %) patients; p = 0.01). The two groups were comparable for all other secondary outcomes.

Conclusion: Treatment with a single 3 mg/kg IFX injection for post-operative peridural lumbar fibrosis-associated sciatica pain does not significantly reduce radicular symptoms at day 10 after injection.

Trial registration: ClinicalTrials.gov NCT00385086 ; registered 4 October 2006 (last updated 15 October 2015).

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow of patients in the trial. IFX Infliximab
Fig. 2
Fig. 2
Changes in a radicular and b lumbar pain scores measured on a visual analog scale over time in patients receiving infliximab and placebo. Box-and-whisker plots represent results expressed in median and interquartile range

References

    1. Robertson JT. Role of peridural fibrosis in the failed back: a review. Eur Spine J. 1996;5(Suppl 1):S2–6. doi: 10.1007/BF00298565. - DOI - PubMed
    1. Burton CV, Kirkaldy-Willis WH, Yong-Hing K, Heithoff KB. Causes of failure of surgery on the lumbar spine. Clin Orthop Relat Res. 1981;157:191–9. - PubMed
    1. Gabriel EM, Friedman AH. The failed back surgery syndrome. In: Wilkins RH, Rengachary DD, editors. Neurosurgery. New York: McGraw-Hill; 1996.
    1. Key JA, Ford LT. Experimental intervertebral-disc lesions. J Bone Joint Surg Am. 1948;30A(3):621–30. - PubMed
    1. Songer MN, Rauschning W, Carson EW, Pandit SM. Analysis of peridural scar formation and its prevention after lumbar laminotomy and discectomy in dogs. Spine (Phila Pa 1976) 1995;20(5):571–80. doi: 10.1097/00007632-199503010-00012. - DOI - PubMed

Publication types

MeSH terms

Associated data